Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders.
Ontology highlight
ABSTRACT: The development of new sequencing technologies in the post-genomic era has accelerated the identification of causative mutations of several single gene disorders. Advances in cell and animal models provide insights into the underlining pathogenesis, which facilitates the development and maturation of new treatment strategies. The progress in biochemistry and molecular biology has established a new class of therapeutics-the short RNAs and expressible long RNAs. The sequences of therapeutic RNAs can be optimized to enhance their stability and translatability with reduced immunogenicity. The chemically-modified RNAs can also increase their stability during intracellular trafficking. In addition, the development of safe and high efficiency carriers that preserves the integrity of therapeutic R
SUBMITTER: Lee MJ
PROVIDER: S-EPMC8773368 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA